Benitec Biopharma's market cap is currently $264.06M. The company's EPS TTM is $-2.973; its P/E ratio is ―; Benitec Biopharma is scheduled to report earnings on February 17, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	$ 216.00K	$ 75.00K	$ 73.00K	$ 59.00K	$ 97.00K
Gross Profit	$ 108.00K	$ -306.00K	$ 64.00K	$ -64.00K	$ -171.06K
Operating Income	$ -22.49M	$ -19.08M	$ -17.85M	$ -13.60M	$ -8.28M
EBITDA	$ -22.49M	$ -18.70M	$ -17.85M	$ -13.60M	$ -7.91M
Net Income	$ -21.75M	$ -19.56M	$ -18.56M	$ -13.78M	$ -8.30M
Balance Sheet
Cash & Short-Term Investments	$ 50.87M	$ 2.48M	$ 4.06M	$ 19.77M	$ 9.80M
Total Assets	$ 52.21M	$ 4.46M	$ 5.97M	$ 21.38M	$ 11.59M
Total Debt	$ 284.00K	$ 559.00K	$ 811.00K	$ 213.00K	$ 405.00K
Net Debt	$ -50.58M	$ -1.92M	$ -3.25M	$ -19.56M	$ -9.40M
Total Liabilities	$ 4.96M	$ 4.26M	$ 3.09M	$ 1.37M	$ 1.35M
Stockholders' Equity	$ 47.25M	$ 202.00K	$ 2.88M	$ 20.01M	$ 10.24M
Cash Flow
Free Cash Flow	$ -19.58M	$ -18.01M	$ -15.91M	$ -13.05M	$ -7.63M
Operating Cash Flow	$ -19.40M	$ -18.01M	$ -15.90M	$ -12.83M	$ -7.54M
Investing Cash Flow	$ -179.00K	$ -1.00K	$ -13.00K	$ -221.00K	$ -94.00K
Financing Cash Flow	$ 68.03M	$ 16.02M	$ 0.00	$ 22.52M	$ 1.77M

Currency in USD

Benitec Biopharma Earnings and Revenue History

Income Statement >

Benitec Biopharma Debt to Assets

Balance Sheet >

Benitec Biopharma Cash Flow

Cash Flow >

Benitec Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing